40% To 60% Acquisition Premiums Seen In Biotech Sector; What Are The Broad-Based Effects?
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
40% To 60% Acquisition Premiums Seen In Biotech Sector; What Are The Broad-Based Effects?
67 WALL STREET, New York – Might 12, 2010 – The Wall Street Transcript has recently published its Biotechnology & Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This Special feature contains expert industry commentary [...]
(AFX UK Focus) 2010-05-13 07:08 French and Benelux stocks – Factors to watch on May 13
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
(AFX UK Focus) 2010-05-13 07:08 French and Benelux stocks – Factors to watch on Might 13
PARIS, Might 13 (Reuters) – Below are company-related news and leading stories from French and Benelux media which could have an impact on the region’s markets or individual stocks.
Read more on Interactive Investor
Why Kiwis should float
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
Why Kiwis should float
There’s no trace of bitterness in David Thorrold’s voice when he talks about the unfortunate of his company BioVittoria’s sharemarket float late last year.
Read more on Marlborough Express
(AFX UK Focus) 2010-05-13 07:10 French and Benelux stocks – Factors to watch on May 13
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
(AFX UK Focus) 2010-05-13 07:10 French and Benelux stocks – Factors to watch on Might 13
PARIS, Might 13 (Reuters) – Below are company-related news and leading stories from French and Benelux media which could have an impact on the region’s markets or individual stocks.
Read more on Interactive Investor
Corrections: IMF would put up 250 billion euros for rescue plan
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
Corrections: IMF would place up 250 billion euros for rescue plan
A MarketWatch report on Might 10 cited an incorrect figure for the amount of the International Monetary Fund’s proposed contribution to an emergency rescue plan in partnership with the European Union. The IMF would remuneration 250 billion, not million, euros under the plan.
Read more on [...]
Some Agreement on Speed Bumps for Market Panics
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
Some Agreement on Speed Bumps for Market Panics
The heads of the major U.S. exchanges have agreed to work on better circuit breakers that would help
Read more on Forbes
Oil slips on euro, caution about rescue
May 16, 2010 by BiotechSector.com
Filed under Biotech Stocks
Oil slips on euro, caution about rescue
Oil futures slipped on Tuesday in volatile trading as traders remained cautious about the $1 trillion rescue package aimed at stabilizing the euro and keeping Greece’s debt problems from spreading.
Read more on Reuters via Yahoo! Canada News
The Bailout Era
May 15, 2010 by BiotechSector.com
Filed under Biotech Stocks
The Bailout Era
With a $1 trillion European bailout fund in place, there’s no other study for the currrent age.
Read more on Forbes
US midday: Dow recovers during morning
May 15, 2010 by BiotechSector.com
Filed under Biotech Stocks
US midday: Dow recovers during morning
LONDON (SHARECAST) – There has been a complete turnaround in the US market during the morning. US stocks fell in primeval dealings but they are currently in positive territory and moving higher.
Read more on ShareCast
US close: Dow lower after weak close
May 15, 2010 by BiotechSector.com
Filed under Biotech Stocks
US close: Dow lower after weak close
LONDON (SHARECAST) – US stocks shut lower after an afternoon rally totally lost momentum in the final hour of trading. Dow Jones shut down 36 points at 10,748. Nasdaq was flat at 2,375 while the S&P 500 gave up 3 at 1,155.
Read more on ShareCast